On May 15, 2019, the District of Columbia Department of Health Care Finance released this letter from the Medicaid Director. The letter pertains to the removal of Prior Authorization (PA) requirements for medication-assisted treatment (MAT) drug products. The purpose of the letter is to replace Transmittal No. 19-11 introducing Policy Number: HCDMA-19-001 which removes the PA requirements for MAT drug products that are prescribed and dispensed for the treatment of opioid use disorder and alcohol use disorder . . .
Restricted Content

You must be an Elite member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!